GUANGZHOU BAIYUNSHAN PHARMACEUTICAL financial statements, including revenue, expenses, profit, and loss
The total revenue of 874 for the last quarter is 19.46 B HKD, and it's 21.70% lower compared to the previous quarter. The net income of Q2 24 is 638.44 M HKD.